Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Megan, Moynahan"'
Autor:
Kim Anderson, Abidemi Ajiboye, Timothy Denison, Jennifer French, Kenneth Gustafson, Kevin Kilgore, Naomi Kleitman, Audrey Kusiak, Brian Litt, Megan Moynahan, Eric Perreault, Douglas Weber, Justin Williams, Dustin Tyler
Publikováno v:
Bioelectronic Medicine, Vol 4, Iss 1, Pp 1-4 (2018)
Abstract The Cleveland Neural Engineering Workshop (NEW) is a biennial meeting started in 2011 as an “unconference” to bring together leaders in the neural engineering and related fields. Since the first iteration of the meeting, NEW has evolved
Externí odkaz:
https://doaj.org/article/5e62652c016b4f5c899738e2ec305d8b
Publikováno v:
Spinal Cord Ser Cases
Study design A cross-sectional stated-preference survey using direct-assessment questions. Objective To determine the relative value placed on different outcomes to be used in a pivotal trial for the upper extremity configuration of the Networked Neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1116e07faa89a40903abcb2b0be2b4
https://europepmc.org/articles/PMC6786403/
https://europepmc.org/articles/PMC6786403/
Autor:
Abidemi B. Ajiboye, Dustin J. Tyler, Eric Perreault, Justin C. Williams, Brian Litt, Kenneth J. Gustafson, Timothy J. Denison, Naomi Kleitman, Jennifer French, Kevin L. Kilgore, Megan Moynahan, Kim Anderson, Audrey N Kusiak, Douglas J. Weber
Publikováno v:
Bioelectronic Medicine
Bioelectronic Medicine, Vol 4, Iss 1, Pp 1-4 (2018)
Bioelectronic Medicine, Vol 4, Iss 1, Pp 1-4 (2018)
The Cleveland Neural Engineering Workshop (NEW) is a biennial meeting started in 2011 as an “unconference” to bring together leaders in the neural engineering and related fields. Since the first iteration of the meeting, NEW has evolved from “j
Autor:
Emily L. Graczyk, Jennifer French, Dawn Bardot, Megan Moynahan, Adeline Zbrzeski, Allison Hess-Dunning, J. Luis Lujan, Winny Tan, Ronald J. Triolo
Publikováno v:
Journal of neural engineering
Autor:
Megan Moynahan
Researchers and companies developing new concepts in neuromodulation will, at some point, find themselves navigating the US Food and Drug Administration (FDA) regulatory programs, whether during the conduct of a clinical trial or at the time market a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a0e4b2e8aac9703ac1ef56a993f61f
https://doi.org/10.1016/b978-0-12-805353-9.00142-x
https://doi.org/10.1016/b978-0-12-805353-9.00142-x
Autor:
Thomas Abell, William T. Abraham, Ali Alabbad, Adnan Al-Kaisy, Paulin Andréll, Richard Andrew McKinley, Claudia A. Angeli, Jeffrey L. Ardell, Anthony Arnold, Musa Audu, Kenneth B. Baker, Giancarlo Barolat, Jonathan Z. Baskin, Girriso F. Benderro, Maria E. Bennett, Marom Bikson, Chad E. Bouton, Una Buckley, Sandra Carvalho, James Cavuoto, John Chae, Jiande D.Z. Chen, Shuo Chen, Joshua A. Cohn, Graham H. Creasey, Christopher J. Czura, Elizabeth G. Damato, William C. de Groat, Michael J. Decker, Anthony F. DiMarco, Laura Dipietro, Roger R. Dmochowski, Michael F. Dorman, Rui V. Duarte, Dominique M. Durand, Robin Elizabeth Germany, Charles Emala, J.P. Errico, Michael Faltys, Manfred Franke, Felipe Fregni, Melanie French, Jason R. Fritz, John P. Gassler, Alejandra Gonzalez Calle, Susan J. Harkema, Magdy Hassouna, Svante Horsch, Mark S. Humayun, Jared M. Huston, Haifeng Jin, Leonardo Kapural, Melissa R. Kaufman, Kevin L. Kilgore, Jayme S. Knutson, Rudi Kobetic, Krzysztof E. Kowalski, Casey G. Kowalik, Elliot S. Krames, Jorge Leite, Yaakov A. Levine, Yanmei Li, James Loudin, Peter L. Lu, Andre G. Machado, Nathaniel S. Makowski, Sachin Malde, D. Michael Ackermann, Douglas F. Milam, Alon Y. Mogilner, Hayat M. Mousa, Megan Moynahan, Drew Murray, Peder S. Olofsson, Raymond P. Onders, P. Hunter Peckham, Laura Perryman, Fabian Piedimonte, Joshua P. Prager, Enrico Rejc, William S. Reynolds, Arun Sahai, Siamak Salavatian, Matthew A. Schiefer, Marabel Schneider, Stefan Schulte, Stephen Selkirk, Marcel Simis, Bruce Simon, Jesse Simon, Jon Snyder, Peter Staats, Kingman P. Strohl, Aurore Thibaut, Simon J. Thomson, Ronald J. Triolo, Dustin J. Tyler, Gozde Unal, Alejandra Vasquez, Timothy Wagner, Connor A. Wathen, James D. Weiland, Blake S. Wilson, Richard D. Wilson, Shukun Yao, Jieyun Yin, Ayhan Yoruk, Ralph Zitnik
Publikováno v:
Neuromodulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::788b1ca65bf3f09281864c3da4fc7aca
https://doi.org/10.1016/b978-0-12-805353-9.01006-8
https://doi.org/10.1016/b978-0-12-805353-9.01006-8
Publikováno v:
Journal of the American College of Cardiology. 46(12):2325-2328
Cardiac resynchronization therapy (CRT) devices have been studied clinically since 1998, and have been on the U.S. market since the Food and Drug Administration (FDA) approval of the first product in 2001. Since that time, the FDA has approved many d
Publikováno v:
Congestive Heart Failure. 11:207-211
Cardiac resynchronization therapy and ventricular assist devices are two of the many US Food and Drug Administration-regulated medical device technologies that are intended for patients with heart failure. Cardiac resynchronization therapy devices ha
Publikováno v:
The Journal of Spinal Cord Medicine. 19:249-254
The purpose of this study was to compare the bone mineral density in children with spinal cord injury (SCI) with age- and sex-matched controls in three anatomic areas of the proximal hip. In addition, post hoc analysis looked for differences in bone
Autor:
Jack W. Judy, Srikanth Vasudevan, Timothy J. Denison, K Skodacek, Meijun Ye, Pavel Takmakov, Joseph J. Pancrazio, Jennifer L. Collinger, Naomi Kleitman, Eugene F. Civillico, Dustin J. Tyler, S Shermer, Michael Hoffmann, Carlos Peña, H Scharen, K Wachrathit, Cristin G. Welle, Gretchen L. Knaack, Jennifer French, John P. Donoghue, Megan Moynahan, Tiffany Ryan, Kip A. Ludwig, Victor Krauthamer, James C. Coburn, Kristen Bowsher, Jose L. Contreras-Vidal, N Getzoff, D Saha, P H Peckham, Vivek Pinto, Leigh R. Hochberg, Douglas J. Weber
Publikováno v:
Journal of Neural Engineering. 13:023001
Objective. The Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) believes it is important to help stakeholders (e.g., manufacturers, health-care professionals, patients, patient advocates, academia, and other gove